Potential mechanisms of cancer stem‐like progenitor T‐cell bio‐behaviours
Clinical and Translational Medicine · 2024-08 · 14 (8)
DOI: 10.1002/ctm2.1817 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical and Translational Medicine, online erschienen am 21.08.2024. Verfasst von Ling Ni. Beteiligte Einrichtung: Institute for Immunology and School of Basic Medicine, Tsinghua University, Beijing, China. Hauptthemen laut MEDLINE: Neoplastic Stem Cells. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
In situations involving continuous exposure to antigens, such as chronic infections or cancer, antigen‐specific CD8 + T cells can become dysfunctional or exhausted. This change is marked by increased expression levels of inhibitory receptors (PD‐1 and Tim‐3). Stem‐like progenitor exhausted (Tpex) cells, a subset of exhausted cells that express TCF‐1 and are mainly found in the lymph nodes, demonstrate the ability to self‐renew and exhibit a high rate of proliferation. Tpex cells can further differentiate into transitional intermediate exhausted (Tex‐int) cells and terminally exhausted (Tex‐term) cells. Alternatively, they can directly differentiate into Tex‐term cells. Tpex cells are the predominant subset that respond to immune checkpoint inhibitors (ICI), making them a prime candidate for improving the efficacy of ICI therapy. This review article aimed to present the latest developments in the field of Tpex formation, expansion, and differentiation in the context of cancer, as well as their responses to ICIs in cancer immunotherapy. Consequently, it may be possible to develop novel treatments that exclusively target Tpex cells, thus improving overall treatment outcomes. Key points Tpex cells are located in lymph nodes and TLS. Several pathways control the differentiation trajectories of Tpex cells, including epigenetic factors, transcription factors, cytokines, age, sex, etc.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute for Immunology and School of Basic Medicine, Tsinghua University, Beijing, China.
ORCID-Profile: Ling Ni
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
Zitieren
APA
Ni, L. (2024). Potential mechanisms of cancer stem‐like progenitor T‐cell bio‐behaviours. Clinical and Translational Medicine, 14(8). https://doi.org/10.1002/ctm2.1817
Vancouver
Ni L. Potential mechanisms of cancer stem‐like progenitor T‐cell bio‐behaviours. Clinical and Translational Medicine. 2024;14(8). doi:10.1002/ctm2.1817
BibTeX
@article{Ni2024,
author = {Ni, Ling},
title = {Potential mechanisms of cancer stem‐like progenitor T‐cell bio‐behaviours},
journal = {Clinical and Translational Medicine},
year = {2024},
volume = {14},
number = {8},
doi = {10.1002/ctm2.1817}
}
EUVIMED